Investigation of the Efficacy of Orientin in Streptozotocin‐Induced Type 1 Diabetes Model and Pancreatic Beta‐TC6 Cells
Journal of Biochemical and Molecular Toxicology · 2026-08 · 40 (8)
DOI: 10.1002/jbt.71047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 22.07.2026. Verfasst von Bengul Ozdemir Sarikaya und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology and Embryology, Faculty of Medicine, Kafkas University, Kars, Turkey. Hauptthemen laut MEDLINE: Flavonoids, Glucosides, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Kafkas Üniversitesi.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetes mellitus is a major endocrine disorder with rapidly increasing global prevalence and numerous systemic complications. Orientin, a flavonoid isolated from various medicinal plants, is known for its potent antioxidant and anti‐inflammatory properties. This study evaluated the protective effects of Orientin in a streptozotocin (STZ)‐induced type 1 diabetes model and in the pancreatic Beta‐TC6 cell line. In the in vivo phase, 42 mice were randomly divided into seven groups, and diabetes was induced by a single intraperitoneal injection of STZ (160 mg/kg). Proinflammatory (IL‐1β, IL‐6) and anti‐inflammatory (TGF‐β, IL‐10) cytokines were measured by ELISA. Pancreatic tissues were evaluated histopathologically (Masson's trichrome, Hematoxylin‐eosin) and immunohistochemically (NF‐κB p65), while oxidative stress parameters (SOD, CAT, GSH, and MDA) were analyzed. In addition, hepatic oxidative stress parameters were assessed, and liver tissues were examined using Periodic Acid–Schiff (PAS) staining. In vitro, the protective effects of Orientin against STZ‐induced damage in Beta‐TC6 cells were investigated. Apoptotic markers (Caspase‐3, Caspase‐9, Bax, and Bcl‐2) were evaluated immunohistochemically, and pyroptotic markers (IL‐1β and Caspase‐1) were analyzed by ELISA. STZ‐induced diabetes increased NF‐κB immunopositivity, proinflammatory cytokines, and oxidative stress in pancreatic tissue. Orientin treatment reduced proinflammatory cytokines, increased anti‐inflammatory cytokines, and improved oxidative stress parameters in both pancreatic and hepatic tissues. In Beta‐TC6 cells, Orientin upregulated Bcl‐2 and downregulated Bax, Caspase‐3, Caspase‐9, Caspase‐1, and IL‐1β levels. These findings suggest that Orientin protects against STZ‐induced pancreatic damage by modulating oxidative stress, inflammation, apoptosis, and pyroptosis, supporting its potential as a therapeutic agent for preserving beta‐cell integrity in diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Histology and Embryology, Faculty of Medicine, Kafkas University, Kars, Turkey.
ORCID-Profile: Bengul Ozdemir Sarikaya, Seyit Ali Bingol
Förderung
- Kafkas Üniversitesi
Zitieren
APA
Sarikaya, B. O., & Bingol, S. A. (2026). Investigation of the Efficacy of Orientin in Streptozotocin‐Induced Type 1 Diabetes Model and Pancreatic Beta‐TC6 Cells. Journal of Biochemical and Molecular Toxicology, 40(8). https://doi.org/10.1002/jbt.71047
Vancouver
Sarikaya BO, Bingol SA. Investigation of the Efficacy of Orientin in Streptozotocin‐Induced Type 1 Diabetes Model and Pancreatic Beta‐TC6 Cells. Journal of Biochemical and Molecular Toxicology. 2026;40(8). doi:10.1002/jbt.71047
BibTeX
@article{Sarikaya2026,
author = {Sarikaya, Bengul Ozdemir and Bingol, Seyit Ali},
title = {Investigation of the Efficacy of Orientin in Streptozotocin‐Induced Type 1 Diabetes Model and Pancreatic Beta‐TC6 Cells},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2026},
volume = {40},
number = {8},
doi = {10.1002/jbt.71047}
}
EUVIMED